# Implantation or Injectable Dosage Form New Animal Drugs; Xylazine
> **Food and Drug Administration** · Final rule. · Published 2003-05-15 · Effective 2003-05-15 · 68 FR 26205
## Document
- **Document number:** 03-12120
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 26205
- **CFR reference:** 21 CFR 522
- **Publication date:** 2003-05-15
- **Effective date:** 2003-05-15
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Lloyd, Inc. The supplemental NADA provides for use of a 300 milligram per milliliter strength of xylazine hydrochloride solution in elk and wild deer to produce sedation, accompanied by a shorter period of analgesia. A food safety cautionary statement regarding the use of xylazine in elk and wild deer (Cervidae) is also being codified for currently approved products.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/05/15/03-12120/implantation-or-injectable-dosage-form-new-animal-drugs-xylazine)
---
*AI Analytics · CC0 1.0*